GB2292888A - Wide spectrum water soluble biocide for medical instruments based on potassium monoperoxysulphate, malic & sulphamic acids, EDTA sodium salt & a glycol ether - Google Patents
Wide spectrum water soluble biocide for medical instruments based on potassium monoperoxysulphate, malic & sulphamic acids, EDTA sodium salt & a glycol ether Download PDFInfo
- Publication number
- GB2292888A GB2292888A GB9417620A GB9417620A GB2292888A GB 2292888 A GB2292888 A GB 2292888A GB 9417620 A GB9417620 A GB 9417620A GB 9417620 A GB9417620 A GB 9417620A GB 2292888 A GB2292888 A GB 2292888A
- Authority
- GB
- United Kingdom
- Prior art keywords
- weight
- biocide
- composition
- total
- disinfectant composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 20
- JZBWUTVDIDNCMW-UHFFFAOYSA-L dipotassium;oxido sulfate Chemical compound [K+].[K+].[O-]OS([O-])(=O)=O JZBWUTVDIDNCMW-UHFFFAOYSA-L 0.000 title claims abstract description 11
- 239000003139 biocide Substances 0.000 title claims description 15
- 238000001228 spectrum Methods 0.000 title abstract description 5
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title description 17
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 title 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 51
- 239000000645 desinfectant Substances 0.000 claims abstract description 34
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 claims abstract description 14
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 8
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000002170 ethers Chemical class 0.000 claims abstract description 8
- 235000011090 malic acid Nutrition 0.000 claims abstract description 8
- 239000001630 malic acid Substances 0.000 claims abstract description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 8
- 230000000249 desinfective effect Effects 0.000 claims abstract description 7
- 239000004094 surface-active agent Substances 0.000 claims abstract description 5
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 230000007797 corrosion Effects 0.000 claims abstract 3
- 238000005260 corrosion Methods 0.000 claims abstract 3
- 239000003112 inhibitor Substances 0.000 claims abstract 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- 230000000844 anti-bacterial effect Effects 0.000 claims description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- -1 molybdates Chemical class 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 230000003253 viricidal effect Effects 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- 235000021317 phosphate Nutrition 0.000 claims description 3
- 230000000855 fungicidal effect Effects 0.000 claims description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 241001502050 Acis Species 0.000 claims 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 150000003851 azoles Chemical class 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
- 150000001565 benzotriazoles Chemical class 0.000 claims 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical class [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 claims 1
- SOCTUWSJJQCPFX-UHFFFAOYSA-N dichromate(2-) Chemical compound [O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O SOCTUWSJJQCPFX-UHFFFAOYSA-N 0.000 claims 1
- 230000003330 sporicidal effect Effects 0.000 claims 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 claims 1
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 15
- 241000233866 Fungi Species 0.000 abstract description 14
- 230000001580 bacterial effect Effects 0.000 abstract description 10
- 241000700605 Viruses Species 0.000 abstract description 7
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 230000002378 acidificating effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 abstract description 3
- 229910052939 potassium sulfate Inorganic materials 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 abstract description 2
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 abstract description 2
- 229910000343 potassium bisulfate Inorganic materials 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 210000004215 spore Anatomy 0.000 description 17
- 239000000243 solution Substances 0.000 description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 210000002845 virion Anatomy 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 210000000170 cell membrane Anatomy 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 150000007523 nucleic acids Chemical class 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000011575 calcium Substances 0.000 description 7
- 230000002070 germicidal effect Effects 0.000 description 7
- 150000007524 organic acids Chemical class 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000010865 sewage Substances 0.000 description 7
- 239000012425 OXONE® Substances 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- OKBMCNHOEMXPTM-UHFFFAOYSA-M potassium peroxymonosulfate Chemical compound [K+].OOS([O-])(=O)=O OKBMCNHOEMXPTM-UHFFFAOYSA-M 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 239000002168 alkylating agent Substances 0.000 description 4
- 229940100198 alkylating agent Drugs 0.000 description 4
- 239000013043 chemical agent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000001086 cytosolic effect Effects 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 241000193470 Clostridium sporogenes Species 0.000 description 3
- 241000607715 Serratia marcescens Species 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000002427 irreversible effect Effects 0.000 description 3
- 230000001665 lethal effect Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 241000193755 Bacillus cereus Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000187480 Mycobacterium smegmatis Species 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108020000999 Viral RNA Proteins 0.000 description 2
- 241000726445 Viroids Species 0.000 description 2
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 2
- 230000003260 anti-sepsis Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 229940040102 levulinic acid Drugs 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000000633 nuclear envelope Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000011151 potassium sulphates Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 210000004777 protein coat Anatomy 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000028070 sporulation Effects 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 101710205660 Calcium-transporting ATPase Proteins 0.000 description 1
- 101710134161 Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type Proteins 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical class ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 239000000253 Denture Cleanser Substances 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000709744 Enterobacterio phage MS2 Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 241000187481 Mycobacterium phlei Species 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- JHECKPXUCKQCSH-UHFFFAOYSA-J calcium;disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate;hydrate Chemical compound O.[Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O JHECKPXUCKQCSH-UHFFFAOYSA-J 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-N disodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound [Na+].[Na+].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O ZGTMUACCHSMWAC-UHFFFAOYSA-N 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229910001448 ferrous ion Inorganic materials 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000008303 genetic mechanism Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910001502 inorganic halide Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 244000000056 intracellular parasite Species 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- JFQQIWNDAXACSR-UHFFFAOYSA-L magnesium malate Chemical compound [Mg+2].[O-]C(=O)C(O)CC([O-])=O JFQQIWNDAXACSR-UHFFFAOYSA-L 0.000 description 1
- 229940096424 magnesium malate Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229940055036 mycobacterium phlei Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- HJKYXKSLRZKNSI-UHFFFAOYSA-I pentapotassium;hydrogen sulfate;oxido sulfate;sulfuric acid Chemical compound [K+].[K+].[K+].[K+].[K+].OS([O-])(=O)=O.[O-]S([O-])(=O)=O.OS(=O)(=O)O[O-].OS(=O)(=O)O[O-] HJKYXKSLRZKNSI-UHFFFAOYSA-I 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940058349 sodium levulinate Drugs 0.000 description 1
- RDKYCKDVIYTSAJ-UHFFFAOYSA-M sodium;4-oxopentanoate Chemical compound [Na+].CC(=O)CCC([O-])=O RDKYCKDVIYTSAJ-UHFFFAOYSA-M 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/02—Sulfur; Selenium; Tellurium; Compounds thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Inorganic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
A biocidal composition for deodorising, cleaning and disinfecting in a single application comprises: (a) from 60 to 90% by weight of potassium monoperoxysulfate; (b) from 2 to 10% by weight of malic acid; (c) from 2 to 6% by weight of sulfamic acid; (d) from 0.25 to 3% by weight of EDTA sodium salt; (e) from 1 to 15% by weight of an alkylated ether of polyethylene glycol surfactant. The peroxygen compound is preferably the a triple salt 2KHSO5 &cirf& KHSO4 &cirf& K2SO4. The material involves acidic activation to give a synergistic formulation with rapid action, and may be blended with corrosion inhibitors. This wide spectrum disinfectant composition is effective against bacteria, fungi, viruses and particularly against bacterial and fungi spores.
Description
WATER SOLUBLE BIOCIDE FOR MEDICAL INSTRUMENTS WITH
WIDE SPECTRUM ACTIVITY BACKGROUND OF TIE INVENTION
It has been known that perishable foods can be preserved by drying, by salting and by acid-producing fermentations, and that chlorinated lime (calcium hypochlorite) can be used to deodorise sewage and garbage (and wounds).
Sterilisation denotes the use of either physical or chemical agents to eliminate all viable microbes from a material while disinfection generally refers to the use of germicidal chemical agents to destroy the potential infectiveness..
Sanitising refers to procedure used to simply lower the bacterial content of utensils used for food. Antisepsis refers to the topical application of chemicals to a body surface to kill or inhibit pathogenic microbes. Disinfectants are widely used for skin antisepsis in preparation for surgery.
Sterilisation of microbes exhibits the kinetics of a first- order reaction, in which the logarithm of the number of survivors decreases as a linear function of time of exposure.
Bacteria are the smallest organisms that contain all the machinery required for growth and self replication. A bacterium includes a rigid cell wall surrounding the cytoplasmic membrane, which itself encloses a single naked chromosome without a nuclear membrane. The cytoplasmic membrane consists primarily of a bi-layer of lipid molecules.
The fundamental criterion of bactericidal action is loss of the ability of the organism to propagate indefinitely, when placed in a suitable environment.
Bactericidal action suggests microbe damage of various types, including the triggering of irreversible damage to the cytoplasmic cell membrane or irreversible impairment of the DNA (or viral RNA replication). Accordingly sterilisation is not identical with destruction of microbes. Additionally, it is understood that damage to nucleic acids (DNA or RNA ) is not always irreversible, as it is known that ultraviolet light-induced damage to viral nucleic acids can be repaired by enyymatic and genetic mechanisms.
Strongly acid and alkaline solutions are actively bactericidal. Indeed, the pH range tolerated by most micro-organisms extends over 3 to 4 units, generally between pH values of about 4.5 to 8; however, mycobacteria are relatively resistance.
At sufficiently high concentrations, many chemicals are bacteriostatic and even bactericidal. The term disinfectant is restricted to chemical agents that are rapidly bactericidal at low concentrations. In contrast to lethal radiation'swhich damage the DNA ( or viral RNA - and to most bactericidal chemotherapeutic agents - which interact irreversibly with various active metabolic systems - most disinfectants act either by dissolving lipids from the cytoplasmic membrane (detergents, lipid solvents ) or by damaging proteins (denaturants, oxidants, alkylating agents, and sulfilydryl reagents ). The rate of killing disinfectants increases with concentration and with temperature.
Different kinds of disinfectants must be used for different purposes, due to the very large variety of microbes.
Chlorine has been used as an antiseptic for more than a century. Chlorine combines with water to form hypochlorous acid, a strong oxidising agent.
Hypochlorite solutions are used to sanitise clean surfaces in the food and the dairy industries and in restaurants; and C1 gas is used to disinfect water supplies and swimming pools.
Alkylating agents e.g. ethylene oxide, replace the labile H atoms on - No, and -OH groups, which are abundant in proteins and nucleic acids (DNA, RNA), and also on -COOH and -SH groups of proteins. Indeed, ethylene oxide has proved to be the most reliable substance available for gaseous disinfection of dry surfaces. However, its use is more expensive a d presents some hazard of residual toxicity (being mutagenic to bacteria and insects). Ethylene oxide is widely used to sterilise heat-sensitive objects: plastic ware; surgical equipment; hospital bedding. These alkylating agents, in contrast to other disinfectants, are nearly as active against spores as against vegetative bacterial cells, because they can penetrate easily and do not require water for their action.
Cationic detergents, e.g. benzalkonium chloride are known to be active against all kinds of bacteria. They act by disrupting the cytoplasmic membrane, causing release of metabolites (the cytoplasmic molecules of the cell); in addition, their detergent action provides the advantage of dissolving lipid films that may protect bacteria.
Fungi are similar to bacteria, yet one of their differences is that their nucleic acid, consisting of multiple chromosomes, is enveloped by a nuclear membrane. In some fungi (as in some bacteria), the cell wall is surrounded by an external capsular polysaccharide which, in the case of bacteria at least, protects the pathogenic microbe from phagocytosis and thus play a major role in determining virulence.
Spores are metabolic by-products in the life cycle of some bacteria and fungi, and are often very resistant to physical and chemical disinfectant agents.
Spores contain one or several nuclei. Fungi produce a variety of exospores, including conidia, chlamydospores (thick walled and very resistant ), and sporangiospores. Bacteria produce endospores. i.e. spores located within the cytoplasm of the parental cell.
Bacterial endospores are differentiated cells formed within a vegetative cell; they encase a genome in an insulating dehydrated vehicle that makes the cell ametabolic and resistant to various lethal agents, but permits subsequent germination in an appropriate medium. Spores are much more resistant than the parental (vegetative) cell to the lethal effect of heat, drying, freezing, toxic chemicals and electromagnetic radiations. Spores are formed by the invagination of a double layer of the cytoplasmic membrane, which closes off to surround a chromosome and a small amount of cytoplasm. A thin spore wall and a thicker cortex with a much looser peptidoglycan are synthesised between the two layers; outside the cortex is a protein coat, rich in disulfide cross-links and constituting up to 80% of the total protein of the spore.The keratin-like impervious properties of the coat account for the resistance to attack by deleterious chemicals, while the dehydration and the presence of a large amount of Calcium and dipicolinate contribute to the heat resistance.
A striking feature of spores is their huge content of Caw, for which active transport units appear in the membrane of the mother cell early during sporulation. Normally the Caw is accompanied by a roughly equivalent amount of dipicolinic acid, which can chelate Ca tt; dipicolinate is almost unique to bacterial spores and may constitute as much as 15% of their weight.
Dehydration and ionic conditions are undoubtedly major factors in stabilising spore proteins. Ca dipicolinate evidently plays a large role, by some as yet unknown mechanism, for its content markedly influences heat resistance.
Recent research results point out to the control of calcium flow across the cytoplasmic membrane, thanks to a "calcium pump" assembly embedded into the bi-layer lipid membrane of cells and defining a calcium selective throughmembrane channel ("The Cycling of Calcium as an Intracellular messenger",
Scientific American, Oct 1989).
A virus consists of a single nucleic acid (either DNA or RNA), and a protein shell or coat surrounding the nucleic acid; the complete viral particle is called a virion. Some viruses contain lipids and carbohydrates. Virions lack constituents fundamental for growth and multiplication, they never "grow": virions are by themselves metabolically inert. Virions multiply (replicate) only after cell- host invasion and therefore are obligatory intracellular parasites.
Hence, a virus is more than a simple nucleoprotein (a chemical substance), but not quite a microbe (a living entity); that is to say a virus is not really "alive" as it is slightly short of the threshold of life as we define it.
Inactivation of virions is the permanent loss of infectivity. The exposure of a population of virions to a chemical (or physical) inactivating agent at a defined concentration for a limited time, results in the inactivation of a proportion of the virions; the others retain infectivity. Therefore, total inactivation cannot be reached with certainty. Viral-inactivating chemical agents include : lipid solvents (effective against enveloped but not naked virions), alkylating agents, e.g. ethylene oxide (effective against all virions); lipolytic enzymes (for some enveloped virions).
A variety of germicides are on the market because of patent rights. For example, Canadian patent 1,290,243 issued 8 Oct 1991 to Thomas AUCHINCLOSS, is directed to a germicide composition comprising five ingredients: an inorganic halide (sodium chloride), an oxidising agent (potassium persulfate triple salt), sulfamic acid, an organic acid (malic acid), and an anhydrous alkali metal phosphate. Enhancement of the virucidal activity of the germicidal composition is claimed, due to alleged buffering and chelating effect of the alkali metal phosphate.
The AUCHINCLOSS patent relates to biocidal (bacteria, fungi, et al) and virucidal compositions. However, a number of drawbacks have been discovered by applicant with respect to such a germicide compound.
(a) it is not effective against bacterial and fungi spores; (b) because it is based on the release of chlorine in contact with an oxidising agent and with non reducible organic acids, it remains of limited scope of activity; (c) because of the presence of chlorine ions in sewage it may give rise to organochlorine derivatives (carcinogenic compounds) and therefore, is undesirable in sewage water; (d) the release of phosphates by the biocidal compound will pollute sewage water, and again for this reason is undesirable in waste water; (e) sodium alkyl sulfate linear, a high foaming agent, is also undesirable in sewage water, since it will substantially reduce the efficiency of the waste water treatment plants;; (f) the lowermost pH level obtained after use of the biocidal composition is not acid enough to meet actual standards of sewage water pH.
OBJECTS OF THE INVENTION
The gist of the invention is therefore to address the need for a wide spectrum disinfectant composition which will be effective against bacteria, fungi, viruses, and particularly against bacterial and fungi spores.
A more specific object of the invention is to produce a disinfectant composition particularly effective against bacterial and fungi spores by disruption of the spore protein coat rick in disulfide cross-links.
DESCRIPTION OF THE INVENTION
Accordingly with the objects of the invention , there is disclosed a disinfectant composition consisting of; (a) from 60 to 90 % by weight of potassium monoperoxysulfate; (b) from 2 to 10% by weight of malic acid; (c) from 2 to 6% by weight of sulfamic acid; (d) from 0.25 to 3% by weight of ethylene diamine tetraacetic acid disodium salt (EDTA Na ); (e) from 1 to 15% by weight of alkylated ether of polyethane glycol; wherein a total of 100% by weight of the composition is obtained. The disinfectant composition is sporicidål, bactericidal, fungicidal and virucidal, as well as cleansing and deodourising.That is to say, the present disinfectant composition will destroy the potential infectivity of bacteria, fungi,bacterial (endo)spores and fungi (exo)spores, as well as inactivate substantially all viroids coming in contact therewith. The molality of the surfactant (alkylated ether of polyethylene glycol) should range between 25 anfd 80.
Preferably, potassium monoperoxysulfate range in weight between 77 to 88% of total composition and most preferably, constitutes about 80%. Similarly, malic acid preferably ranges between 3 and 8% and most preferably constitutes about 4% by weight of total composition. Similarly, sulfamic acid preferable ranges between 3 to 6%, and most preferably constitutes 4% by weight of total composition.Similarly, EDTA Na2 preferably ranges between 1 and 2 % and most preferably constitutes 2% by weight of total coinposition. Similarly, alkylated ether of polyethylene glycol preferably ranges between 3 and 10%, and most preferably constitutes 10% by weight of total composition.
The present disinfectant composition has a wide spectrum of efficacity, while no phosphate is released. The disinfecting system is based entirely upon decomposition of potassium monoperoxysulfate, by irreducible organic acids, thus releasing hydrogen peroxide and eventually oxygen. Again there is no contamination of sewage water by phosphate ions. The use of non-ionic detergent allows for penetration through the lipidic walls of some microorganisms, thus reaching thenucleic avoid of the cell (or viroid) to damage same and therefore prevent growth (or viral replication). The further use of non-ionic detergent creates but a small amount of foam, avoiding the inhibition of performance of mechanical equipment used in the treatment of waste water and permits a high degree of degradation 90+%. No colouring or flavouring (polluting) agents are added.
Potassium peroxymonosulfate will oxidise halide ions into halogens, ferrous ions into ferric, manganous ions into manganic and hydrogen peroxide into oxygen. Potassium peroxymonosulfate can initiate the free radical polymerization of typical vinyl monomers, e.g. vinyl acetate, ethyl acrylate and acrylonitrile. Potassium peroxymonosulfate is currently used as a bleaching agent in denture cleansers, toilet-bowl cleaners and laundry dry-bleachers.
Potassium peroxymonosulfate is also known for use in removing chloramines in swimming pools and as a disinfectant.
Accordingly, the active ingredient in the present disinfectant composition is potassium peroxymonosulfate, in that a byproduct of the dilution reaction is the potassium hydrogen sulfate, which will lower the pH of the solution.
Potassium sulfate is present within the triple salt, but is not directly involved in the above noted reaction.
The use of organic acids gives rise to the formation of hydrogen peroxide, which disinfecting properties are well known. (HzO, also non pollutant)
Malic acid is a fairly strong organic acid, and a good chelating agent of di-and trivalent metal ions. It is non toxic. Sulfamic acid is also a strong organic acid with low toxicity.
The EDTA Nanas been incorporated to the present disinfectant composition in order to chelate the magnesium and calcium ions, in view of: (a) removing calcium ions, thus softening the water and enhancing the detersive (disinfecting) action; (b) removing levulinic acid under the form of sodium levulinate, thus increasing likelihood of cytoplasmic membrane disruption and therefore easing access to the nucleic acid for the disinfecting agent.
Moreover, the presence of an equal percentage of malic and sulfamic acid produces a close to ideal range of acidity, to ensure the complete release of hydrogen peroxide. Finally, the present disinfectant composition is freely soluble in cold, tepid or warm water, and it can be used at tremendous ranges of concentrations (from 1 to 20 g per 100 ml of solution).
Since the oxyethylenated glycol surfactant has a high power of wetting action and is non-ionic, it will promote bacterial and fungus cytoplasmic wall disruption about the bi-layer lipid component thereof, thus releasing cytoplasmic metabolites and enabling inactivation of the growth-dependent nucleic acid.
The heart of the invention lies in the release of oxygen from synergistic effect of the various ingredients present in this disinfectant composition. Indeed the organic acids ensure low pH levels, essential for continuous and lengthy release of oxygen from the oxidising agent, potassiurn menoperoxysulfate. The chelating agent, EDTA Na (ethylene diamine tetraacetic acid disodium salt) deprives microbes from levulinic acid and calcium ions, (thus inducing sporulation, when applicable). The low foaming surface active agent will facilitate penetration of the cytoplasmic membrane and will enable the active agent to reach the nucleic acid of the microbe.
Indeed, the synergism is verified by the release of oxygen by the potassium peroxymonosulfate when in acidic medium, giving rise to formation of hydrogen peroxide and sulfuric acid. The malic and sulfamic acid provide at their selected concentrations proper acidic conditions.
Th pH of a 1% weight by volume concentration of the composition is about 2. IS. After contact with the waste, the pH goes up to about 6.5, depending on the nature of the material being treated. e.g. organic and body fluids, protein load. The end products are mainly potassium sulfate, resulting from the catalysis of potassium monoperoxysulfate, and sulfates of iron and sodium.
Potassium, calcium and magnesium malate are also found, as is EDTA calcium.
There are no organo-chlorine products present because thare are no halogenic ions in this composition. Any chlorine compound present in the waste material would be oxidised to hypochlorous acid and then to the halogen which would then combine with sulfamic acid to form chlorosulfonic acid and also combine with Na or K ions resulting in a chloride.
The disinfecting efficiency of the present composition has been verified by applicant during experiments conducted over a wide variety of microbes, to assess the disinfectant action of different formulations of the present composition: (a) viruses : herpes, adenovirus, parvovirus, coronavirus, paramyxovirus, rhabdovirus, retrovirus.
(b) (bacterial) endospores: clostridium sporogenes (c) bacteria: streptococcus faecal is staphyl ococcus aureus, salmonella typhimurium, pseudomonas aerginosa, salmonell a choleraesuis, eschericha coli, enterobacter spp., klebsiella pneumonia, serratia marcescens.
(d) fungi: Candida albicans, aspergillus flavus, trichophyton mentagrophytes, penicillium, spp.
EXPERIMENT 1
Various microbes were submitted to a 5% weight by volume concentration of a germicide composition consisting of the following ingredients: potassium monoperoxysulfate: 80% by weight malic acid 4% by weight sulfamic acid : 4% by weight
EDTA Na salt: 2% by weight alkylated ether of polyethylene glycol: 10% by weight.
The growth inhibition percentage rate of the microbes relative to defined contact time were as follows:
Serratia marcescens: 99.999999% (10 minutes)
Escherichia coli: 100% (30 min)
Klebsiella pnellmoniae: 100% (30 min)
Pseudomonas aeruginosa: 100% (30 min)
Mycobacterium phlei: 100% (30 min)
Bacteriophage MS-2 : 99.99944% (7 min)
Mycobacterium smegmatis: 99 98154 (10 min)
Clostridium sporogenes 99.9999984% (10 min)
Bacillus subtilis 99.9583333% (10 min)
Bacillus cereus : 99.9858823% (10 min)
Bacillus stearothermophilus: 99.2131147% (10 min)
Saccharomyces cerevisiiae : 99.999840% (10 min)
EXPERIMENT 2
Various microbes were submitted to a 5% weight by volume concentration of a germicide composition consisting of the following ingredients: potassium monoperoxysulfate : 80% by weight malic acid: 8% by weight sulfamic acid: 3% by weight EDTA Na salt : 0.5% by weight alkylated ether of polyethylene glycol: 8.5% by weight.
The growth inhibition percentage rate of the microbes relative to defined contact time were as follows:
Serratia marcescens : 100% (10 minutes)
Mycobacterium smegmatis: 99.99769 (10 min) Clostridium sporogenes: 99.999972% (15 min)
Bacillus subtilis : 99.9750% (10 min)
Bacillus cereus : 99.99999% (10 min)
Bacillus stearothermpphilus : 98.4852459% (10 min)
Saccharomyces serevisiae : 99.992272% (10 min)
The present disinfectant (powder) composition is specifically for use in cleaning instruments, floors and bedding and generally speaking for use in hospitals, bio-medical research centres: health centres, veterinary hospitals and clinics. Contact with the skin is not recommended because of the high pH of the composition; however, it is not corrosive. It is freely soluble in cold water.
Directions for use can be summarised as follows: (a) routine cleaning and disinfection : prepare and wash with a 0.5% by weight solution of the present composition (e.g. 25 g in litres of water).
(b) terminal disinfection of various areas : wash carefully with a 1% solution of the present composition (e.g. 50g in 5 litres of water).
(c) disinfection of laboratory ware : if heavily soiled, soak in a 1% solution for 10 minutes, then rinse with running water. If lightly soiled, use a 1% solution of the present composition.
(d) disinfection of ambient air: a mechanical or manual sprayer may be used (there is increased risk of infection caused by a high degree of humidity) to vaporise a 0.2% by weight solution of the present composition (e.g. 10g in 5 litres of water). With spores or other highly resistant microbes or where important organic loads (faeces, blood, urine ) are present, the concentration of the present disinfectant composition could be increased to 5% weight by volume, and the contact time increased. Also a 0.2% weight by volume solution of the present composition could be applied in the form of spray (manually or mechanically).
It is understood that a 1% solution of the present disinfecting solution is not irritating to the skin; however, contact with eyes and mucous membranes should be avoided. The present composition should be stored in a cool, dry place separate from other chemicals. A 1% solution of this disinfectant will loose 20% of its potency after ten days. It is best to use the solution within two days from dilution of the powder composition.
Claims (14)
1. A biocidal composition for deodorising, cleaning and disinfecting in a single application consisting of: (a) from 60 to 90% by weight of potassium monoperoxysulfate; (b) from 2 to 10% by weight of malio acid.
(c) from 2 to 6% by weight of sulfamic acid (d) from 0.25 to 3% by weight of EDTA da,; (e) from 1 to 15% by weight of an al:kyIatee'ther of polyethylene glycol surfactant; a total of 1 0/o by weight of the composition being obtained wherein said disinfectant is bactericidal, fungicidaL sporicidal and virucidal.
2. A biocide as defined in claim 1, wherein the molality of said alkylated ether of polyethylene glycol ranges between 25 and 80.
3. A biocide as defined in claim 2, wherein said potassium monoperoxysulfate ranges between 77 and 88% by weight of the total disinfectant composition.
4. A biocide as defined in claim 3, wherein said potassium monoperoxysulfate constitutes about 80% by weight of the total disinfectant composition.
5. A biocide as defined in claim 2, wherein said malic acid ranges between 3 and 8% by weight of the total disinfectant composition.
6. A biocide as defined in claim 5, wherein said malic acis constitutes about 4% by weight of the total disinfectant composition.
7. A biocide as defined in claim 2, wherein said sulfamic acid ranges between 3 and 6% by weight of the total disinfectant composition.
8. A biocide as defined in claim 7, wherein said sulfamic acid constitutes about 4% by weight of the total disinfectant composition.
9. A biocide as defined in claim 2, wherein said EDTA Na ranges between 1 and 2% by weight of the total disinfectant composition.
10. A biocide as defined in claim 9, wherein said EDTA Na constitutes about 2% by weight of the total disinfection composition.
11. A biocide as defined in claim 2, wherein said allcyiated ether of polyethylene glycol ranges between 3 and 10% by weight of the total disinfectant composition.
12. A biocide as defined in claim 11, wherein said alkylated ether of polethylene glycol constitutes about 10% by weight of the total disinfectant composition.
13. A biocide as defined in claim 12, which contains selected corrosion inhibitors.
14. A biocide as defined in claim 13 which contains but not restricted to corrosion inhibitor such as :benzotriazoles, tolytriazoles, mercaptobensathiozol, azoles, benzoate, molybdates, phosphates, chromates, dichromate's, tungstate, vanadate, borate, and benzoyl alanines.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9417620A GB2292888A (en) | 1994-09-02 | 1994-09-02 | Wide spectrum water soluble biocide for medical instruments based on potassium monoperoxysulphate, malic & sulphamic acids, EDTA sodium salt & a glycol ether |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9417620A GB2292888A (en) | 1994-09-02 | 1994-09-02 | Wide spectrum water soluble biocide for medical instruments based on potassium monoperoxysulphate, malic & sulphamic acids, EDTA sodium salt & a glycol ether |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9417620D0 GB9417620D0 (en) | 1994-10-19 |
| GB2292888A true GB2292888A (en) | 1996-03-13 |
Family
ID=10760695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9417620A Withdrawn GB2292888A (en) | 1994-09-02 | 1994-09-02 | Wide spectrum water soluble biocide for medical instruments based on potassium monoperoxysulphate, malic & sulphamic acids, EDTA sodium salt & a glycol ether |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2292888A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5928948A (en) * | 1997-03-10 | 1999-07-27 | Steris Corporation | Method for the assessment and validation of cleaning processes |
| AU2002353061B2 (en) * | 2001-12-05 | 2008-07-10 | Aseptica, Inc. | Anti-microbial systems and methods |
| EP1628655A4 (en) * | 2003-06-04 | 2008-10-15 | Tyco Healthcare | ANTISEPTIC COMPOSITIONS, PROCESSES AND SYSTEMS |
| EP2022331A1 (en) * | 2007-08-02 | 2009-02-11 | Wesso Ag | Disinfectant for reducing the number of bacteria and biofilms |
| EP3574759A1 (en) * | 2018-06-01 | 2019-12-04 | LANXESS Deutschland GmbH | Disinfectant composition |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2078522A (en) * | 1980-06-26 | 1982-01-13 | Antec Ah International Ltd | Improvements in and relating to sanitizing compositions |
| US4459217A (en) * | 1981-07-22 | 1984-07-10 | Reckitt & Colman Products Limited | Denture cleansing compositions |
-
1994
- 1994-09-02 GB GB9417620A patent/GB2292888A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2078522A (en) * | 1980-06-26 | 1982-01-13 | Antec Ah International Ltd | Improvements in and relating to sanitizing compositions |
| US4459217A (en) * | 1981-07-22 | 1984-07-10 | Reckitt & Colman Products Limited | Denture cleansing compositions |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5928948A (en) * | 1997-03-10 | 1999-07-27 | Steris Corporation | Method for the assessment and validation of cleaning processes |
| AU2002353061B2 (en) * | 2001-12-05 | 2008-07-10 | Aseptica, Inc. | Anti-microbial systems and methods |
| US8541472B2 (en) | 2001-12-05 | 2013-09-24 | Aseptica, Inc. | Antiseptic compositions, methods and systems |
| EP1628655A4 (en) * | 2003-06-04 | 2008-10-15 | Tyco Healthcare | ANTISEPTIC COMPOSITIONS, PROCESSES AND SYSTEMS |
| EP2022331A1 (en) * | 2007-08-02 | 2009-02-11 | Wesso Ag | Disinfectant for reducing the number of bacteria and biofilms |
| EP3574759A1 (en) * | 2018-06-01 | 2019-12-04 | LANXESS Deutschland GmbH | Disinfectant composition |
| WO2019228980A1 (en) * | 2018-06-01 | 2019-12-05 | Lanxess Deutschland Gmbh | Disinfectant composition |
| US11427485B2 (en) | 2018-06-01 | 2022-08-30 | Lanxess Deutschland Gmbh | Disinfectant composition |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9417620D0 (en) | 1994-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5186946A (en) | Disinfectant with wide spectrum germicidal activity | |
| US9034390B2 (en) | Anti-microbial composition and method for making and using same | |
| CN103501605B (en) | A stable composition of HOCl, processes for its production and uses thereof | |
| CA2911464C (en) | High osmolarity antimicrobial composition containing one or more organic solvents | |
| US8940792B2 (en) | Antimicrobial composition and methods for using same | |
| CN104981158B (en) | Disinfectant | |
| US20090074881A1 (en) | Antimicrobial cidality formulations with residual efficacy, uses thereof, and the preparation thereof | |
| CN100407923C (en) | A kind of bactericidal disinfectant and its application | |
| Marriott et al. | Sanitizers | |
| JP7058490B2 (en) | Antibacterial composition that suppresses viruses, bacteria and fungi | |
| US20070264355A1 (en) | Binary compositions and methods for sterilization | |
| KR101913718B1 (en) | Compositions for sterilization and disinfection comprising octenidine and benzalconium chloride | |
| CA2569025C (en) | Powdered composition for the generation of peracetic acid and use thereof to sanitize surfaces | |
| Boothe | Antiseptics and disinfectants | |
| CA2062006C (en) | Disinfectant with wide spectrum germicidal activity | |
| CA2028930A1 (en) | Stable hypochlorous acid sterilizing solution and kit | |
| GB2292888A (en) | Wide spectrum water soluble biocide for medical instruments based on potassium monoperoxysulphate, malic & sulphamic acids, EDTA sodium salt & a glycol ether | |
| US6462088B1 (en) | Disinfecting preparation containing chlorine in alcohol | |
| JPS6143322B2 (en) | ||
| JP2000107265A (en) | Alkaline ion agent for sterilization and disinfection | |
| EP1637168B1 (en) | Use of a dialkylketone peroxide as biocidal, sterilizing, antiseptic, disinfecting and anti-parasitic agent | |
| JP2003267813A (en) | Disinfectant composition liquid and disinfecting method | |
| US20070286907A1 (en) | Germicide composition | |
| Phalalo et al. | An Enzymatic Based Formulation for Cleaning and Disinfection of Medical Devices | |
| FERNANDES et al. | Surface Disinfection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |